Vericiguat and hypotension in patients with heart failure and reduced ejection fraction: VERIFY-HF registry
Although hypotension was relatively common soon after starting vericiguat, they were not often associated with drug discontinuation. Patients experiencing hypotension had a greater risk of HF outcomes, but this would be primarily associated with their vulnerability, given the infrequent discontinuation.
Authors
- Yukihiro Watanabe (ORCID: https://orcid.org/0000-0003-0382-8703)
- Kenji Kanenawa (ORCID: https://orcid.org/0000-0002-9276-327X)
- Keisuke Kida (ORCID: https://orcid.org/0000-0002-3464-6016)
- Hiromasa Hayama (ORCID: https://orcid.org/0000-0001-6702-7150)
- Koki Takegawa (ORCID: https://orcid.org/0009-0004-3120-218X)
- Yusuke Nakano (ORCID: https://orcid.org/0000-0002-9314-3427)
- Takanori Ikeda (ORCID: https://orcid.org/0000-0003-0096-438X)
- Daisuke Miyahara (ORCID: https://orcid.org/0000-0001-7736-0299)
- Tomohiro Kaneko (ORCID: https://orcid.org/0000-0001-9355-2418)
- Toshiyuki Yanai (ORCID: https://orcid.org/0009-0003-9067-8885)
- Kazuya Ikeda (ORCID: https://orcid.org/0000-0003-3671-5940)
- Tetsuya Amano
- Daiki Akagaki
- Hiroki Matsuzoe (ORCID: https://orcid.org/0000-0002-9180-1334)
- Wataru Fujimoto (ORCID: https://orcid.org/0000-0001-8832-7435)
- Reiji Goto
- Yuichiro Iida (ORCID: https://orcid.org/0000-0001-5062-3255)
- Tomohiro Onishi (ORCID: https://orcid.org/0000-0003-0633-9323)
- Y Yazaki (ORCID: https://orcid.org/0000-0003-4976-1022)
- Tatsuhiro Shibata (ORCID: https://orcid.org/0000-0002-0477-210X)
- Yu Takigami
- Ryohei Ono (ORCID: https://orcid.org/0000-0002-4875-7470)
- Koshiro Kanaoka (ORCID: https://orcid.org/0000-0001-7900-7835)
- Takahito Nasu (ORCID: https://orcid.org/0000-0001-5631-6870)
- Toru Takase
- Riku Arai (ORCID: https://orcid.org/0000-0003-0995-5957)
- Ryuichi Matsukawa (ORCID: https://orcid.org/0000-0002-1204-2123)
- Takeshi Kitai
- Koichiro Matsumura (ORCID: https://orcid.org/0000-0002-9089-3505)
- Takeshi Ijichi (ORCID: https://orcid.org/0000-0002-1950-7616)
- Katsunori Fukumoto
- Seiji Ikegami (ORCID: https://orcid.org/0000-0001-6732-8121)
- Atsushi Shibata (ORCID: https://orcid.org/0000-0001-9701-8730)
- Nobuyuki Kagiyama (ORCID: https://orcid.org/0000-0002-2305-0049)
- Keijiro Nakamura (ORCID: https://orcid.org/0000-0002-1580-0890)
- S. Matsumoto (ORCID: https://orcid.org/0000-0002-2000-1954)
- Satomi Ishihara (ORCID: https://orcid.org/0000-0002-2816-4926)
- Yu Saito
- Shunsuke Ishii (ORCID: https://orcid.org/0000-0003-2111-6304)
- Daiki Suzuki
- Akira Sakamoto (ORCID: https://orcid.org/0000-0002-5652-1791)
- Gaku Nakazawa (ORCID: https://orcid.org/0000-0003-2315-9658)
- Yasuyuki Shiraishi (ORCID: https://orcid.org/0000-0001-8788-1186)
- Kodai Shibao
- Shoichiro Nohara
- Arai Keiko
- Atsushi Kikuchi
- Yoshiaki Kubota
- Takashi Morinaga (ORCID: https://orcid.org/0000-0001-7545-0186)
- Yosuke Oka
- Kota Okabe
- Takuya Takigahira
- Takashi Nakaoji
- Junna Takuwa
Institutions
- Kurume University (JP)
- Toho University (JP)
- Tokai University (JP)
- Iwate Medical University (JP)
- Keio University (JP)
- Juntendo University (JP)
- Hyogo Prefectural Awaji Medical Center (JP)
- National Cerebral and Cardiovascular Center (JP)
- Kitasato University (JP)
- Nara Medical University (JP)
- Kindai University (JP)
Publication Details
- Journal
- American Heart Journal
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1016/j.ahj.2025.09.013
- Citations
- 2
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.78